355 related articles for article (PubMed ID: 19817713)
1. Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.
Reale M; Greig NH; Kamal MA
Mini Rev Med Chem; 2009 Sep; 9(10):1229-41. PubMed ID: 19817713
[TBL] [Abstract][Full Text] [Related]
2. Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.
Boyko AA; Troyanova NI; Kovalenko EI; Sapozhnikov AM
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211044
[TBL] [Abstract][Full Text] [Related]
3. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
4. Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.
Lindestam Arlehamn CS; Garretti F; Sulzer D; Sette A
Curr Opin Immunol; 2019 Aug; 59():115-120. PubMed ID: 31430650
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
[TBL] [Abstract][Full Text] [Related]
6. Highlighting Immune System and Stress in Major Depressive Disorder, Parkinson's, and Alzheimer's Diseases, with a Connection with Serotonin.
Correia AS; Cardoso A; Vale N
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445231
[TBL] [Abstract][Full Text] [Related]
7. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors.
Araujo DM; Lapchak PA
Neuroscience; 1994 Aug; 61(4):745-54. PubMed ID: 7838374
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.
Kim S; Seo JH; Suh YH
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S9-13. PubMed ID: 15109581
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections).
Ringheim GE; Conant K
J Neuroimmunol; 2004 Feb; 147(1-2):43-9. PubMed ID: 14741426
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressive aspects of estrogen].
Ciesielska A
Neurol Neurochir Pol; 2003; 37 Suppl 3():79-92. PubMed ID: 14560702
[TBL] [Abstract][Full Text] [Related]
11. [Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy].
Litvinenko IV; Krasakov IV; Bisaga GN; Skulyabin DI; Poltavsky ID
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6. Vyp. 2):3-10. PubMed ID: 28980606
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
Front Immunol; 2018; 9():2122. PubMed ID: 30283455
[TBL] [Abstract][Full Text] [Related]
13. Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer's and Parkinson's Disease Patients.
Unda SR; Antoniazzi AM; Altschul DJ; Marongiu R
Dement Geriatr Cogn Disord; 2021; 50(2):143-152. PubMed ID: 34058741
[TBL] [Abstract][Full Text] [Related]
14. Immune responses in neurodegenerative diseases.
Shrestha R; Shakya Shrestha S; Millingtona O; Brewer J; Bushell T
Kathmandu Univ Med J (KUMJ); 2014; 12(45):67-76. PubMed ID: 25219999
[TBL] [Abstract][Full Text] [Related]
15. The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease.
Sim KY; Im KC; Park SG
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722559
[TBL] [Abstract][Full Text] [Related]
16. The role of Th17 cells in auto-inflammatory neurological disorders.
Tahmasebinia F; Pourgholaminejad A
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):408-416. PubMed ID: 28760387
[TBL] [Abstract][Full Text] [Related]
17. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease.
Bayer AU; Keller ON; Ferrari F; Maag KP
Am J Ophthalmol; 2002 Jan; 133(1):135-7. PubMed ID: 11755850
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease in patients with Alzheimer's disease.
Leverenz J; Sumi SM
Arch Neurol; 1986 Jul; 43(7):662-4. PubMed ID: 3729742
[TBL] [Abstract][Full Text] [Related]
19. Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer's and Parkinson's Disease.
Soursou G; Alexiou A; Ashraf GM; Siyal AA; Mushtaq G; Kamal MA
Curr Drug Metab; 2015; 16(8):705-12. PubMed ID: 26560322
[TBL] [Abstract][Full Text] [Related]
20. Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease.
Freedman M
Brain Cogn; 1990 Nov; 14(2):134-43. PubMed ID: 2285509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
